Cargando…
Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis
Pyrazinamide is an important component of both drug-susceptible and drug-resistant tuberculosis treatment regimens. Although approximately 50% of rifampin-resistant isolates are also resistant to pyrazinamide, pyrazinamide susceptibility testing is not routinely performed due to the challenging natu...
Autores principales: | Whitfield, Michael G., Engelthaler, David M., Allender, Christopher, Folkerts, Megan, Heupink, Tim H., Limberis, Jason, Warren, Robin M., Van Rie, Annelies, Metcalfe, John Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769725/ https://www.ncbi.nlm.nih.gov/pubmed/34757831 http://dx.doi.org/10.1128/JCM.01907-21 |
Ejemplares similares
-
How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?
por: Ng, Kamela C. S., et al.
Publicado: (2019) -
Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System
por: Demers, Anne-Marie, et al.
Publicado: (2016) -
Quantitative (1)H Nuclear Magnetic Resonance Assay for the Rapid Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis from Sputum Samples
por: Lopez, Juan M., et al.
Publicado: (2023) -
MODS-Wayne, a Colorimetric Adaptation of the Microscopic-Observation Drug Susceptibility (MODS) Assay for Detection of Mycobacterium tuberculosis Pyrazinamide Resistance from Sputum Samples
por: Alcántara, Roberto, et al.
Publicado: (2019) -
Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study
por: Meldau, Richard, et al.
Publicado: (2019)